Page last updated: 2024-10-22

pimagedine and Optic Nerve Diseases

pimagedine has been researched along with Optic Nerve Diseases in 2 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Optic Nerve Diseases: Conditions which produce injury or dysfunction of the second cranial or optic nerve, which is generally considered a component of the central nervous system. Damage to optic nerve fibers may occur at or near their origin in the retina, at the optic disk, or in the nerve, optic chiasm, optic tract, or lateral geniculate nuclei. Clinical manifestations may include decreased visual acuity and contrast sensitivity, impaired color vision, and an afferent pupillary defect.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pang, IH1
Johnson, EC1
Jia, L1
Cepurna, WO1
Shepard, AR1
Hellberg, MR1
Clark, AF1
Morrison, JC1
Ino-ue, M1
Ohgiya, N1
Yamamoto, M1

Other Studies

2 other studies available for pimagedine and Optic Nerve Diseases

ArticleYear
Evaluation of inducible nitric oxide synthase in glaucomatous optic neuropathy and pressure-induced optic nerve damage.
    Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:4

    Topics: Aged; Animals; Caenorhabditis elegans Proteins; Disease Models, Animal; Enzyme Inhibitors; Gene Expr

2005
Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats.
    Brain research, 1998, Aug-03, Volume: 800, Issue:2

    Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relation

1998